Neurology paper "Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study" Table e-1
<p>Our Neurology 2020 paper titled "<span><a><b>Sequence of Alzheimer disease biomarker changes </b></a><b>in cognitively normal </b></span><b>adults: A cross-sectional study" explores the cascades of </b>changes of several well-known Alzheimer disease (AD) markers including cerebrow spinal fluid (CSF), imaging (PET-PIB and MRI) and cognitive markers in cognitively normal participants. The baseline marker data of participants is modeled as a piecewise linear function of baseline age allowing one change point, without and with adjustment for covariates. The change point of a marker incicates the acceleration time of point after which a greater percentage of the participants present preclinical AD compared to before the change point. Cosnistent with previous research, the study confirmed that Abeta42 showed the earliest change-point around 50 years old and cognition had a late change point around 62. The study further found Tau, pTau and MRI hippalcampal volume had their change point closer to cognition. We identified change points in all participants, as well as by stratification of APOE4 status. The data here displays the Supplemental table Table e-1 accompanying the paper where the change point results by stratification of APOE4 status are presented.</p> <div> <div> <div class="msocomtxt"> </div> </div> </div> <p> </p>
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 0
- Harmonization
- 12
- Access
- 12
- Reuse readiness
- 0
- Engagement
- 8
Dataset details
- Repository
- dryad
- Published
- June 23, 2021
- License
- cc-zero
- DOI
- 10.5061/dryad.x69p8czfs
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.